Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613600 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness Study of a Fiber Supplement for Weight Loss
A Phase 2 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00613600 is a Phase 2 study that has completed, run by Rush University Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT00613600, a Phase 2 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
Overweight and obesity are serious and growing problems within the United States. The usual approaches to weight loss-dieting, exercise, and behavioral interventions-rarely result in long-term weight loss. Therefore, we will evaluate the safety and efficacy of glucomannan, a fiber supplement that has promising weight loss effects.
Interventions
- DIETARY_SUPPLEMENT Glucomannan
- DIETARY_SUPPLEMENT Inert microcrystalline cellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00613600
The ClinicalTrials.gov registry entry for NCT00613600 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glucomannan is the first listed.
NCT00613600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00613600 about?
NCT00613600 is a clinical study titled "Safety and Effectiveness Study of a Fiber Supplement for Weight Loss". Overweight and obesity are serious and growing problems within the United States. The usual approaches to weight loss-dieting, exercise, and behavioral interventions-rarely result in long-term weight loss. Therefore, we will evaluate the safety and efficacy of glucomannan, a fiber supplement that ha...
What is the current status of trial NCT00613600?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2008-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00613600?
The interventions under investigation include: Glucomannan (DIETARY_SUPPLEMENT), Inert microcrystalline cellulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00613600?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.